Related Experiment Video
Updated: Oct 1, 2025

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
French legislation on retrospective clinical research: What to know and what to do
1Department of Digestive, Minimally Invasive & Oncologic Surgery, Montpellier University Hospital Center, 641, avenue du Doyen-Gaston-Giraud, 34090 Montpellier, France; University of Montpellier, 34090 Montpellier, France.
Abstract:
The French legislation on human subject research known as the Jardé law of 5th March 2012 has been applicable since November 2016. It concerns all research involving human subjects (RIPH, in French) and is defined according to 3 categories: high-risk interventional RIPH, low-risk interventional RIPH and non-interventional RIPH. This recent development in the supervision of research on human subjects had several objectives: to redefine the various categories of research, to strengthen data protection and to effectively address the ethical guidelines of international journals. The levels of constraint differ between categories of research according to level of risk, the common objective being to ensure patient protection. Retrospective studies based on information drawn from medical records or other databases, which are widely used in the surgical field, are not covered by the Jardé law. However, they require approval by local ethics committees and compliance with European legislation on personal data protection. Simplified procedures have been set up by the research and innovation departments in our university hospitals. In this update, we shall synthesize the legal prerequisites applying to retrospective studies on data from medical files.
Related Concept Videos
Drug Regulation
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Legal Guidelines for Documentation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview

